(EL) EssilorLuxottica S. A. - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000121667

EL: Eyewear, Lenses, Sunglasses, Contact Lenses, Optical Equipment

EssilorLuxottica Société anonyme, a global leader in the design, production, and distribution of ophthalmic lenses, eyewear, and related technologies, operates across six continents, serving diverse markets in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. The companys extensive portfolio includes corrective lenses, sunglasses, frames, and contact lenses under renowned brands such as Essilor, Varilux, Crizal, Ray-Ban, Oakley, and many others. It also offers specialized products like reading glasses and Blue Light filtering solutions under brands like Eyezen and Stellest.

Beyond consumer products, EssilorLuxottica provides advanced diagnostic and treatment solutions for eye care professionals. This includes multimodal imaging platforms like SPECTRALIS for comprehensive eye diagnostics, ANTERION for anterior segment imaging, and HEYEX 2 for integrated device management. The company also manufactures high-tech equipment for optical laboratories under the Satisloh brand, covering surfacing, polishing, coating, and finishing processes. Additionally, EssilorLuxottica supplies optometry instruments and tools for vision assessment, fitting, and medical record-keeping, catering to opticians, prescription laboratories, and healthcare institutions.

EssilorLuxottica distributes its products through a vast network of independent opticians, distributors, e-commerce platforms, and large retail chains. It also operates a significant brick-and-mortar retail presence and online sales channels, directly reaching consumers worldwide. Established in 1849 and headquartered in Paris, France, the company underwent a significant transformation in 2018 with the merger of Essilor International and Luxottica, creating a global eyecare and eyewear giant.

Ticker Symbol: EL Exchange: PA Type: common stock Country Origin: France GICS Sub Industry: Health Care Equipment

3-Month Forecast: Based on and , EssilorLuxottica is expected to experience moderate price volatility. The stocks short-term moving averages (SMA20: 255.17, SMA50: 269.34) suggest a potential downtrend, with the last price (247.30) trading below these levels. The ATR (7.50) indicates manageable volatility. Fundamentally, the high P/E (47.35) and forward P/E (31.35) signal a premium valuation, while the Return on Equity (RoE: 11.51) reflects stable profitability. The stock may face resistance near the SMA50 level, with support expected around the SMA200 (233.76). Investors should monitor the companys ability to maintain its premium valuation amid rising interest rates and slowing economic growth.

Additional Sources for EL Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EL Stock Overview

Market Cap in USD 132,949m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception

EL Stock Ratings

Growth Rating 89.2
Fundamental 61.1
Dividend Rating 75.3
Rel. Strength 27.8
Analysts -
Fair Price Momentum 285.07 EUR
Fair Price DCF 322.60 EUR

EL Dividends

Dividend Yield 12m 3.36%
Yield on Cost 5y 7.84%
Annual Growth 5y 27.99%
Payout Consistency 98.0%

EL Growth Ratios

Growth Correlation 3m -57.9%
Growth Correlation 12m 91.5%
Growth Correlation 5y 92.2%
CAGR 5y 19.75%
CAGR/Max DD 5y 0.67
Sharpe Ratio 12m 0.34
Alpha 19.34
Beta 0.664
Volatility 37.23%
Current Volume 534.6k
Average Volume 20d 644.3k
What is the price of EL stocks?
As of April 26, 2025, the stock is trading at EUR 253.30 with a total of 534,593 shares traded.
Over the past week, the price has changed by +0.04%, over one month by -8.62%, over three months by -1.67% and over the past year by +28.15%.
Is EssilorLuxottica S. A. a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, EssilorLuxottica S. A. (PA:EL) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.08 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EL as of April 2025 is 285.07. This means that EL is currently undervalued and has a potential upside of +12.54% (Margin of Safety).
Is EL a buy, sell or hold?
EssilorLuxottica S. A. has no consensus analysts rating.
What are the forecast for EL stock price target?
According to ValueRays Forecast Model, EL EssilorLuxottica S. A. will be worth about 314 in April 2026. The stock is currently trading at 253.30. This means that the stock has a potential upside of +23.98%.
Issuer Forecast Upside
Wallstreet Target Price 273.3 7.9%
Analysts Target Price - -
ValueRay Target Price 314 24%